Resveratrol ameliorates PM2.5-aggravated IBS-D.
Resveratrol ameliorates PM-aggravated IBS-D mouse symptoms by restoring the gut bacteria and hypoxanthine/linoleic acid metabolism homeostasis.
AI Summary
Key Findings
Abstract
Fine particulate matter (PM) is an emerging environmental risk factor for gut disorders. Still, the toxicity of PMin diarrhea-predominant irritable bowel syndrome (IBS-D) mice and the intervention role of resveratrol remain unclear. This study integrated non-targeted metabolomics and gut microbiota analysis in mice of IBS-D, PMexposure, and resveratrol + PM+ IBS-D. The colonic histopathology, oxidative stress, colon barrier function, and visceral hypersensitivity were detected. Results showed that PMsignificantly exacerbated IBS-D symptoms in mice. Such effects were accompanied by gut microbiota dysbiosis and distinct alterations in fecal metabolites. This study identified an imbalance in faecal microbiota composition in IBS-D and PM+ IBS-D mice, triggering alterations in hypoxanthine and linoleic acid metabolism pathways. Resveratrol alleviated the aggravated IBS-D symptoms by restoring the metabolic pathways. These findings demonstrate that PMexacerbates IBS-D by disrupting gut microbiota and specific metabolites related to metabolism pathways, and that resveratrol counteracts these effects.
Affiliation
Tang Li
External References
- PubMed ID:
- 42521107
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.